ARTICLE | Company News
Pharmacia, Celltech in arthritis deal
March 5, 2001 8:00 AM UTC
PHA and Celltech (LSE:CCH; CLL) will co-develop and co-promote worldwide CCH's CDP 870 TNF-alpha humanized antibody fragment for rheumatoid arthritis (RA) and Crohn's disease. PHA will pay $50 million...